No internet connection — showing the saved version of the page.

Novo Nordisk A/S

DEEUR
← to the screener

Novo Nordisk A/S (US:NONOF) — Biotechnology: Pharmaceutical Preparations. Number of exchanges where the company shares trade: 3. On this page — price and chart, dividends, top holders and share count history.

⚠ Don't mix them up: there is another company with the same or a very similar name. It is a separate record — check the ticker, exchange and registration number.

About the company

Website
novonordisk.com
Sector
Health Care · Biotechnology: Pharmaceutical Preparations
Headquarters
BAGSVAERD DENMARK, Denmark
CEO
Maziar Mike Doustdar
Employees
66 700
Shares outstanding
3.34 B
Free float
3.17 B
Market cap
150.93 B EUR
Insiders
5.27%
Institutions
33.78%
Industry (SIC)
Pharmaceutical Preparations
Legal form
ZRPO
ISIN
DK0060534915
LEI
549300DAQ1CVT6CXN342
Payout ratio
50.5%
FCF
59.0 B DKK
Payout / FCF
88%
Debt
143 B DKK
2.0 y of FCF
Dividend streak
24 y
Earnings, FCF and dividends paid — for the 12 months to 31.12.2025 (the company's latest report).
Description

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. The company has a collaboration with Anthropic accelerate the development of new medicines and advance AI-driven software development. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. It has a strategic collaboration with Orbis Medicines to discover and develop oral macrocycle therapeutics for cardiometabolic diseases. The company was formerly known as Novo Industri A/S and changed its name to Novo Nordisk A/S in April 1989. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

advertisement

Exchanges and tickers

ExchangeTickerCurrencyPriceType
XETRA XetraNOV primaryEUR33.21 +0.00%common stock
LSE London Stock Exchange0QIU IOBGBP257.55 +1.45%common stock
US USA StocksNONOF OTCUSD38.84 -1.61%common stock

Price for 3 months

up day down day dividend ex-date payment dateHover / tap a day — open, close, high and low prices

Dividends

Per year, US:NONOF: 11.7 DKK (2 paym.)

Novo Nordisk A/S (NONOF) pays dividends twice a year. Per year (12 months up to and including the latest announced payment): 11.7 DKK per share (payments: 2). Based on payment history, the next ex-dividend date is expected around 15.02.2027. Uninterrupted dividend history: 24 years.

Ex-datePaymentAmount%TypeTicker
2026-08-172026-08-183.7500 DKK1.2/3.9 %semi-annualUS:NONOF
2026-03-302026-03-317.9500 DKK3.4/5.0 %semi-annualUS:NONOF
2025-08-182025-08-193.7500 DKK1.1/3.4 %semi-annualUS:NONOF
2025-03-312025-04-017.9000 DKK1.7/2.5 %semi-annualUS:NONOF
2024-08-162024-08-193.5000 DKK1.4/3.8 %semi-annualUS:NONOF
2024-03-222024-03-266.4000 DKK2.5/≈4.9 %semi-annualUS:NONOF

Top holders

HolderStakeSharesReport date
VANGUARD STAR FUNDS-Vang…1.38%46.88 M2026-07-31
EuroPacific Growth Fund-…1.07%36.2 M2026-06-30
VANGUARD TAX-MANAGED FUN…0.92%31.13 M2026-06-30
Capital World Growth & I…0.77%26.02 M2026-06-30
iShares Trust-iShares Co…0.71%24.13 M2026-08-31
Income Fund of America0.52%17.78 M2026-07-31
Dodge & Cox Funds-Dodge…0.39%13.1 M2026-06-30
Fidelity Concord Street…0.37%12.52 M2026-07-31
iShares Trust-iShares MS…0.34%11.48 M2026-08-31
Capital Income Builder0.3%10.32 M2026-07-31
Cygnus Capital Advisors,…0%78 8002026-06-30
Generali Investments Cee…0%27 3992026-06-30
Pacer Advisors, Inc.0%24 4102026-06-30
Atlas Capital Advisors I…0%5 2182026-06-30
Novo Holdings———
Novo Nordisk Foundation———